Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2014
Source ID
10.1016/j.immuni.2014.11.014

Entities

People

  • Barton Haynes
  • Christina Stolarchuk
  • David C. Montefiori
  • David Easterhoff
  • Faruk Sinangil
  • Frederick H. Jaeger
  • Garnett Kelsoe
  • Georgia D. Tomaras
  • Hua-Xin Liao
  • Jaranit Kaewkungwal
  • Jerome H Kim
  • Kan Luo
  • Kevin Wiehe
  • Krissey E. Lloyd
  • Laura L Sutherland
  • Lynn Morris
  • M Anthony Moody
  • Mattia Bonsignori
  • Nathan I Nicely
  • Nelson Michael
  • Punnee Pitisuttithum
  • Richard M Scearce
  • Robert Parks
  • Ruijun Zhang
  • S Moses Dennison
  • S. Munir Alam
  • Sampa Santra
  • Sanjay Phogat
  • Sorachai Nitayaphan
  • Supachai Rerks-ngarm
  • Thomas B. Kepler
  • Todd Bradley

Organizations

  • Duke University
  • Gates Foundation
  • Henry M. Jackson Foundation for the Advancement of Military Medicine
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • Office of Basic Energy Sciences
  • United States Army Medical Research and Development Command
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology